Beyond Chronic Myelogenous Leukemia: Potential Role for Imatinib in Philadelphia-Negative Myeloproliferative Disorders

Jorge Cortes, Hagop Kantarjian

Research output: Contribution to journalReview articlepeer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'Beyond Chronic Myelogenous Leukemia: Potential Role for Imatinib in Philadelphia-Negative Myeloproliferative Disorders'. Together they form a unique fingerprint.

Medicine & Life Sciences